Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2)

C Grey, R Jackson, S Wells, S Thornley, R Marshall… - Heart, 2014 - heart.bmj.com
Objective To describe patterns of statin use and predictors of poor maintenance over a 3-
year period following an acute coronary syndrome (ACS). Methods National hospitalisation …

Trends in use of high-intensity statin therapy after myocardial infarction, 2011 to 2014

RS Rosenson, ME Farkouh, M Mefford, V Bittner… - Journal of the American …, 2017 - jacc.org
Background: Data prior to 2011 suggest that a low percentage of patients hospitalized for
acute coronary syndromes filled high-intensity statin prescriptions upon discharge. Black …

Adherence tradeoff to multiple preventive therapies and all-cause mortality after acute myocardial infarction

MJ Korhonen, JG Robinson, IE Annis… - Journal of the American …, 2017 - jacc.org
Background: Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor
blockers (ARB), beta-blockers and statins are recommended after acute myocardial …

Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb

KP Alexander, ED Peterson, CB Granger… - Journal of the American …, 1998 - jacc.org
Objectives. The purpose of this study to determine whether use of cardiac medications
reflects evidence-based recommendations for patients with non–ST elevation acute …

Trends in adherence to secondary prevention medications in elderly post‐myocardial infarction patients

NK Choudhry, S Setoguchi, R Levin… - … and drug safety, 2008 - Wiley Online Library
Background Poor levels of medication adherence for patients with coronary heart disease
(CHD) have been documented but it is unclear whether adherence has improved over time …

Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapies

NK Choudhry, T Brennan, M Toscano, C Spettell… - American heart …, 2008 - Elsevier
BACKGROUND: Medication nonadherence is a major public health problem, especially for
patients with coronary artery disease. The cost of prescription drugs is a central reason for …

Effect of use of combination evidence-based medical therapy after acute coronary syndromes on long-term outcomes

R Lahoud, M Howe, SM Krishnan, S Zacharias… - The American journal of …, 2012 - Elsevier
Several medications have individually been shown to reduce mortality in patients with acute
coronary syndromes (ACS), but data on long-term outcomes related to the use of …

Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery

A Goyal, JH Alexander, GE Hafley, SH Graham… - The Annals of thoracic …, 2007 - Elsevier
BACKGROUND: Secondary prevention medications are beneficial after acute coronary
syndromes, but these benefits are less clear after coronary artery bypass graft surgery. We …

Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction

SV Arnold, JA Spertus, FA Masoudi… - Journal of the American …, 2013 - jacc.org
Objectives: The aim of this study was to examine the prescribing patterns of medications
quantified by the performance measures for acute myocardial infarction (AMI). Background …

Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease

RS Rosenson, ST Kent, TM Brown, ME Farkouh… - Journal of the American …, 2015 - jacc.org
Background: National guidelines recommend use of high-intensity statins after
hospitalization for coronary heart disease (CHD) events. Objectives: This study sought to …